Prosecution Insights
Last updated: May 29, 2026

ETH ZÜRICH

13 pending office actions • 10 art units • 12 examiners • 0 of 13 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

13
Total Pending OAs
9
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
4
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (4)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (8%)
11
Medium (85%)
1
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (8%)
§103 only9 (69%)
§102 only2 (15%)
§112 only1 (8%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
46% of docket
2
Information Tech
15% of docket
0
Communications
0% of docket
2
Semiconductors
15% of docket
3
Mechanical / Eng
23% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

130 h
Manual time on pending OAs
26 h
Time saved (low, 20%)
46 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MERCADO, GABRIEL S 2 42.7% +26.7%
LANE, DANIEL E 1 4.1% +8.6%
WOOD, BLAKE ANDREW 1 71.6% +13.9%
CHANG, JOSEPH 1 89.6% +4.0%
HERNANDEZ, JACKSON J 1 52.8% +51.5%
MENEFEE, JAMES A 1 80.6% +12.1%
ROBARGE, TYLER ROGER 1 76.0% +1.9%
KLINKEL, KORTNEY L 1 39.5% +44.6%
ALLEN, MICHAEL D 1 32.6% +48.7%
CASE, SARAH CATHERINE 1 34.9% +49.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18041321 CASCADE LASERS MENEFEE, JAMES A 103d overdue
18263140 Electrical converter and method for operating an electrical converter CHANG, JOSEPH 42d overdue

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18000242 RNA MOLECULES FOR THE TREATMENT OF CANCER ALLEN, MICHAEL D 183d overdue
19103245 METHOD FOR DETERMINING A FATIGUE VALUE OF A PERSON LANE, DANIEL E 42d

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18000242 RNA MOLECULES FOR THE TREATMENT OF CANCER ALLEN, MICHAEL D 183d overdue
18001075 SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION KLINKEL, KORTNEY L 147d overdue
18041321 CASCADE LASERS MENEFEE, JAMES A 103d overdue
17568212 METHODS AND SYSTEMS FOR MODIFYING USER INPUT PROCESSES MERCADO, GABRIEL S 50d overdue
17910706 ADDITIVE FOR CEMENT-FREE BUILDING MATERIALS CASE, SARAH CATHERINE 15d overdue
18394287 ROBOTICS DEVICE CONTROL SIGNALS BASED ON MOVEMENT DATA WOOD, BLAKE ANDREW 9d
18142195 METHODS AND SYSTEMS FOR GENERATING AND PROVIDING USER INPUT RECOMMENDATIONS FOR RESPONDING TO A RECEIVED MESSAGE MERCADO, GABRIEL S 27d
18001074 SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCER HERNANDEZ, JACKSON J 29d

Top Art Units

Art UnitApps
3658 2
1627 2
2171 2
3715 1
2849 1
2828 1
1671 1
1731 1
1691 1
1672 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19103245 METHOD FOR DETERMINING A FATIGUE VALUE OF A PERSON LANE, DANIEL E 3715 §102 Non-Final OA 42d Pending Feb 12, 2025
18394287 ROBOTICS DEVICE CONTROL SIGNALS BASED ON MOVEMENT DATA WOOD, BLAKE ANDREW 3658 §103 Non-Final OA 9d Pending Dec 22, 2023
18263140 Electrical converter and method for operating an electrical converter CHANG, JOSEPH 2849 §103 Non-Final OA 42d overdue Pending Jul 27, 2023
18001074 SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCER HERNANDEZ, JACKSON J 1627 §103 Final Rejection 29d Pending Jun 22, 2023
18142195 METHODS AND SYSTEMS FOR GENERATING AND PROVIDING USER INPUT RECOMMENDATIONS FOR RESPONDING TO A RECEIVED MESSAGE MERCADO, GABRIEL S 2171 §103 Non-Final OA 27d Pending May 02, 2023
18041321 CASCADE LASERS MENEFEE, JAMES A 2828 §103 Non-Final OA 103d overdue Pending Feb 10, 2023
18093761 SYSTEM AND METHOD FOR DESIGNING ROBOT MECHANISMS WITH FLEXIBLE LINKS ROBARGE, TYLER ROGER 3658 §103 Non-Final OA 57d Pending Jan 05, 2023
18001075 SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION KLINKEL, KORTNEY L 1627 §102 Non-Final OA 147d overdue Pending Dec 08, 2022
18000242 RNA MOLECULES FOR THE TREATMENT OF CANCER ALLEN, MICHAEL D 1671 §101 Non-Final OA 183d overdue Pending Nov 29, 2022
17910706 ADDITIVE FOR CEMENT-FREE BUILDING MATERIALS CASE, SARAH CATHERINE 1731 §103 Final Rejection 15d overdue Pending Sep 09, 2022
17568212 METHODS AND SYSTEMS FOR MODIFYING USER INPUT PROCESSES MERCADO, GABRIEL S 2171 §103 Final Rejection 50d overdue Pending Jan 04, 2022
17603908 METHOD AND KIT FOR THE PURIFICATION OF FUNCTIONAL RISC-ASSOCIATED SMALL RNAS SHIAO, YIH-HORNG 1691 §103 Final Rejection 71d overdue Pending Oct 14, 2021
17046559 MAMMALIAN MHC PEPTIDE DISPLAY AS AN EPITOPE SELECTION TOOL FOR VACCINE DESIGN KINSEY WHITE, NICOLE ERIN 1672 §112 Non-Final OA 26d Pending Oct 09, 2020

Managing ETH ZÜRICH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month